In support of this concept, we recently demonstrated an interferon (IFN)-inducible blood signature in patients with pulmonary TB from London and South Africa [4], which has now been validated in three independent studies in Africa [5], [6] and Indonesia [7]. Here, IFNA1 is linked to pulmonary tuberculosis.